Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal Prasterone for Vaginal Atrophy (ERC-231)
NCT01256684Phase 3Completed
- Sponsor
- Endoceutics
- Start
- Dec 2010
- Primary completion
- Aug 2011
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 3 trial of prasterone in vaginal atrophy, sponsored by Endoceutics. Started Dec 2010; status: completed.
02
Drugs
prasterone
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT01256684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256684.